New Study Reveals How Smoking Disrupts Lung-Brain Communication to Raise Dementia Risk
Smoking Disrupts Lung-Brain Communication, Raising Dementia Risk

Groundbreaking research has uncovered a novel biological mechanism through which smoking may significantly elevate the risk of developing dementia, including Alzheimer's disease. A study from the University of Chicago suggests that nicotine exposure disrupts vital communication channels between the lungs and the brain, establishing a previously unknown 'lung-brain' axis that contributes to cognitive decline.

The Nicotine-Triggered Pathway

Previous epidemiological studies have long established that heavy smoking in midlife more than doubles the risk of dementia decades later. This new research, published in the journal Science Advances, provides a potential biological explanation for this troubling connection.

The investigation focused on specialised lung cells known as pulmonary neuroendocrine cells (PNECs). Researchers discovered that when these cells are exposed to nicotine, they release tiny particles called exosomes. These exosomes travel from the lungs and interfere with how the brain regulates iron—a process absolutely critical for maintaining healthy nerve cells and proper neurological function.

Wide Pickt banner — collaborative shopping lists app for Telegram, phone mockup with grocery list

Disrupted Iron Balance and Neuronal Damage

The study reveals that the exosomes released by nicotine-exposed lung cells disrupt the brain's delicate iron balance. This disruption can damage neurons, place significant stress on their energy systems, and contribute to the pathological processes associated with neurodegenerative diseases like Alzheimer's and Parkinson's.

'This research establishes a clear "lung-brain" axis that may help explain why cigarette smoking is linked to cognitive decline,' said co-author and postdoctoral researcher Kui Zhang. The findings indicate that the lung acts not merely as a passive target for smoke exposure but as an active signalling organ that directly influences brain health.

Laboratory Models and Future Therapeutic Potential

The study relied on laboratory models and stem-cell-derived pulmonary neuroendocrine cells to demonstrate this mechanism. While the results are scientifically promising, the researchers emphasize that more comprehensive studies are needed to confirm this pathway operates identically in human subjects.

'The lung is not just a passive target of smoke exposure, but an active signalling organ influencing brain health,' explained co-author Assistant Professor Joyce Chen of the UChicago Pritzker School of Molecular Engineering and the Ben May Department for Cancer Research.

The research team is now actively exploring whether blocking these exosomes could eventually lead to new therapeutic approaches that protect the brain from smoke-induced damage. This could have significant implications for both prevention strategies and potential treatments for smoking-related cognitive decline.

UK Smoking Trends and Policy Responses

This scientific discovery comes at a critical juncture in Britain's public health landscape. While the national smoking rate has fallen to a record low of 9.1% of adults (approximately 4.9 million people) in 2024, progress has slowed considerably, and some regions are experiencing concerning reversals with increased smoking compared to a decade ago.

Simultaneously, vaping has overtaken traditional smoking for the first time in the UK, with an estimated 5.4 million adults now using e-cigarettes—particularly among younger demographic groups. Public health experts caution that declining cigarette sales do not always translate directly into equivalent reductions in smoking rates, as some individuals switch to vaping or seek non-legal tobacco products.

Legislative Measures for a Smoke-Free Generation

In response to these trends, ministers are seeking to accelerate progress through the proposed Tobacco and Vapes Bill, which aims to create a 'smoke-free generation.' The legislation would make it illegal for anyone born on or after 1 January 2009 to ever purchase tobacco products legally.

The comprehensive bill also includes measures to tighten controls on vaping, including:

Pickt after-article banner — collaborative shopping lists app with family illustration
  • Restrictions on advertising and marketing
  • Limitations on flavours that appeal to younger users
  • Stricter packaging regulations

More than 1,200 health professionals—including doctors, nurses, and public health leaders—have endorsed these proposals, stating they are essential to reduce smoking prevalence and prevent a new generation from developing nicotine addiction. This research from Chicago provides additional scientific urgency to these public health efforts by elucidating the specific neurological risks associated with smoking.